Our Board of Directors
Accomplished, Experienced, Strategic, Leaders
Jared Bauer, MBA
Mr. Bauer joined IONIQ Sciences in September 2018. Mr. Bauer has focused his professional endeavors on the medtech industry and is also the CEO of Cibus Biotechnologies Inc. In 2012, Mr. Bauer acquired BurnFree Products, and in just two years with a focus on sustainable revenue generation, led the team to expand BurnFree distribution to 58 countries, managing regulatory processes, re-working quality systems and making BurnFree the second largest burn treatment product line in the world. Mr. Bauer currently serves as a trustee of The Oliver Fund, a non-profit he co-founded, Chairman of the BioUtah SLC Biotech Initiative Advisory Committee, Board member of the BioHive, and recently served as an adjunct professor of entrepreneurship at Ensign College. He holds a BS in Economics from the University of Utah, and an MBA from Boise State University.
Jim Hogan, MBA
Mr. Jim Hogan joined the Board in mid-2019. He served his entire professional career in the medtech industry in multiple locations in the USA and abroad. After rising to the role of Director of Sales and Marketing for Pfizer Europe in London, he successfully founded two medtech companies and led two others. These four start-up medtech companies were all successfully exited. Mr. Hogan recently retired from Medtronic, one of the world’s largest medtech companies where he was President of Medtronic Latin America, corporate Vice President, and appointed to the company’s Sr. Executive Committee. Mr. Hogan has deep operational, sales, marketing, and general management expertise with medical devices and therapeutics in some of the smallest and largest medtech companies in the world. Mr. Hogan remains dedicated to health-related philanthropic endeavors from his home in Park City, Utah. Mr. Hogan holds a BA in Chemistry and Psychology in addition to a MBA from the University of Minnesota.
Mr. Don Patterson joined the Board in mid-2019. He began his professional career in public accounting and worked for both large and small firms as a CPA for 24 years. During this time, he developed expertise in financial analysis and was significantly involved in merger and acquisition (M&A) activities. He has been involved in multiple boards of directors for companies ranging in size from small, closely-held companies to large privately-held, publicly listed companies. He has been one of the founders in various entrepreneurial ventures, including manufacturing, distribution, intellectual property (IP) development and prosecution. His primary pursuit for the past 19 years has been in the development and licensing of patents involving manufacturing processes used in the home products industry. Mr. Patterson currently resides in Gilbert, Arizona and holds a BA degree in accounting from Arizona State University.
Rich McKeown, JD
Mr. McKeown re-joined the IONIQ Sciences Board in 2019, as Leavitt Partners’ corporate designee, after previously serving on the IONIQ (formerly ProLung) Board from 2014-2017. Mr. Rich McKeown is the co-founder and Chairman of the Leavitt Partners Board of Directors. He served as chief of staff for Mike Leavitt at the U.S. Department of Health and Human Services (HHS). He also led the negotiations between China and the FDA regarding Drug, Device and Food issues which led to landmark agreements in 2008 and paved the way for the placement of US-FDA offices around the world. Prior to his public service in Washington, D.C., Mr. McKeown served as chief of staff to Governor Mike Leavitt and as commissioner of the Utah State Tax Commission. Mr. McKeown currently resides in Salt Lake City, Utah and received his juris doctorate from the University of Utah and bachelor’s degree from Ohio University.
Michael Garff, MBA
Mr. Garff joined IONIQ Sciences as the Chief Operating Officer in June 2009. At IONIQ, he obtained Breakthrough Device Designation from the US FDA and European regulatory approval (Conformité Européene or CE Mark) for the ProLung Test. Mr. Garff also designed and implemented a certified ISO 13485 quality management system, organized manufacturing as well as manages the clinical trial process that includes contracting with premier cancer hospitals for trial sites. Currently, Mr. Garff oversees IONIQ’s product development, manufacturing, clinical studies, regulatory affairs, FDA submissions, quality audits, data analysis, and patents. Prior to IONIQ, he was involved with the Pierre Lassonde Entrepreneur Center where he served as a Director. While there he helped launch several biomedical companies. He holds a BS in Business Finance and an MBA from the University of Utah.
David Nielsen, MBA
Mr. David Nielsen joined the Board in mid-2019. He has 20 years of R&D and leadership experience at BioFire and BioFire Defense (formerly named Idaho Technology), which sold to bioMérieux in 2014. As one of the original Idaho Technology employees, Mr. Nielsen worked in various roles in engineering, management, and business development rising to the position of Vice President of Product Development. He managed a team of more than 70 scientists and engineers who were responsible for developing and launching new medical diagnostic products and supporting the complex regulatory clearance process in the US, EU, and other countries. Mr. Nielsen is currently a partner at SaltRidge, a medtech product development company and Chair/COO of Advanced Conceptions, a start-up in the fertility space. Mr. Nielsen holds a BS degree in Mechanical Engineering from BYU plus a Master of Mechanical Engineering and MBA from the University of Utah.